机构风向标 | 恩威医药(301331)2025年二季度已披露前十大机构累计持仓占比71.13%

Group 1 - Enwei Pharmaceutical (301331.SZ) released its semi-annual report for 2025, indicating that as of August 25, 2025, 11 institutional investors held a total of 73.5785 million shares, accounting for 71.51% of the total share capital [1] - The top ten institutional investors collectively held 71.13% of the shares, with a slight decrease of 0.22 percentage points compared to the previous quarter [1] - One public fund, Rongtong Health Industry Flexible Allocation Mixed A/B, reported a decrease in holdings by 0.46% compared to the previous quarter [1] Group 2 - One new foreign institutional investor disclosed during this period is China International Capital Corporation Hong Kong Asset Management Limited - CICCFT10(Q) [2]